IRIS
BARICICH, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.191
NA - Nord America 1.748
SA - Sud America 526
EU - Europa 304
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 46
OC - Oceania 4
Totale 4.956
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.673
SG - Singapore 1.372
BR - Brasile 445
CN - Cina 347
VN - Vietnam 214
IT - Italia 110
HK - Hong Kong 61
IN - India 46
DE - Germania 34
AR - Argentina 30
CA - Canada 29
FR - Francia 26
BD - Bangladesh 24
GB - Regno Unito 24
MX - Messico 20
PL - Polonia 18
RU - Federazione Russa 18
TR - Turchia 16
ID - Indonesia 14
ZA - Sudafrica 14
NL - Olanda 13
UZ - Uzbekistan 13
EC - Ecuador 12
ES - Italia 12
MA - Marocco 12
AT - Austria 9
IQ - Iraq 9
MY - Malesia 9
VE - Venezuela 9
CL - Cile 8
CO - Colombia 8
JP - Giappone 8
PY - Paraguay 8
UA - Ucraina 8
JM - Giamaica 7
PK - Pakistan 7
SE - Svezia 7
CR - Costa Rica 5
KR - Corea 5
NP - Nepal 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
AU - Australia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
KE - Kenya 3
LT - Lituania 3
SV - El Salvador 3
TN - Tunisia 3
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EG - Egitto 2
FI - Finlandia 2
HR - Croazia 2
IL - Israele 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
IE - Irlanda 1
IR - Iran 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
NA - Namibia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
TG - Togo 1
TH - Thailandia 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 4.821
Salva come PNG Salva come JPEG
Città #
Singapore 564
San Jose 364
Ashburn 306
The Dalles 218
Dallas 144
Beijing 96
Shanghai 88
Ho Chi Minh City 78
Hong Kong 55
Santa Clara 52
Hanoi 45
Los Angeles 44
Milan 42
New York 35
São Paulo 33
Buffalo 28
Council Bluffs 23
Rome 17
Warsaw 17
Rio de Janeiro 16
Charlotte 15
Atlanta 13
Prineville 13
Fort Worth 12
Haiphong 12
Montreal 12
Orem 12
Chicago 11
Tashkent 11
Belo Horizonte 10
Chennai 8
Mexico City 8
Orlando 8
Tokyo 8
Biên Hòa 7
Boston 7
Denver 7
Fortaleza 7
Guayaquil 7
Lauterbourg 7
Mumbai 7
Naples 7
Philadelphia 7
Stockholm 7
Amsterdam 6
Brooklyn 6
Curitiba 6
Düsseldorf 6
Johannesburg 6
Manchester 6
Recife 6
Caracas 5
Caxias do Sul 5
Hải Dương 5
Las Vegas 5
London 5
Marília 5
Miami 5
Ninh Bình 5
Phoenix 5
Porto Alegre 5
Quito 5
San Francisco 5
Springfield 5
Toronto 5
Amman 4
Ankara 4
Anápolis 4
Baghdad 4
Brasília 4
Campinas 4
Everett 4
Frankfurt am Main 4
Houston 4
Kingston 4
Maceió 4
Niterói 4
Nuremberg 4
Pasadena 4
Poplar 4
Reston 4
Santiago 4
Silver Spring 4
Sorocaba 4
São José dos Campos 4
Tallmadge 4
Trumbull 4
Turin 4
Vienna 4
Addis Ababa 3
Athens 3
Bien Hoa 3
Buenos Aires 3
Bắc Ninh 3
Campo Grande 3
Cape Town 3
Caratinga 3
Casablanca 3
Ciudad del Este 3
Da Nang 3
Totale 2.729
Salva come PNG Salva come JPEG
Nome #
Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxin 109
ROLE OF EARLY BOTULINUM TOXIN TYPE A INJECTION IN THE TREATMENT OF PATIENTS WITH POSTSTROKE SPASTICITY: PRELIMINARY RESULTS OF AN OBSERVATIONAL STUDY 104
La valutazione dell’outcome nel percorso riabilitativo della protesi di ginocchio 93
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 89
Sensor based assessment of turning during instrumented Timed Up and Go Test for quantifying mobility in chronic stroke patients 83
RIEDUCAZIONE DEL CAMMINO NEL MORBO DI PARKINSON: TRATTAMENTO ROBOTIZZATO VERSUS TRAINING SU TREADMILL. STUDIO RANDOMIZZATO CONTROLLATO 72
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 63
What is the impact of robotic rehabilitation on balance and gait outcomes in people with multiple sclerosis? A systematic review of randomized control trials 56
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 55
Ageing, functioning patterns and their environmental determinants in the spinal cord injury (SCI) population: A comparative analysis across eleven European countries implementing the International Spinal Cord Injury Community Survey 55
Capitolo "Strumenti di cura: Programma farmacologico" in: Foti C, Monticone M. "Manuale di medicina fisica e riabilitativa". EDRA, Milano, 2021 55
Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials 54
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 54
Valutazione comparativa di tre diversi protocolli riabilitativi post-inoculo di tossina botulinica A sull’ipertono spastico dell’arto inferiore 53
Buccal hemineglect: is it useful to evaluate the differences between the two halves of the oral cavity for the multidisciplinary rehabilitative management of right brain stroke survivors? A cross-sectional study 53
Variations of muscle activity patterns in free weight versus flywheel resistance front squat: a pilot study 52
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 52
Pain, disability, and quality of life in participants after concurrent onabotulinumtoxinA treatment of upper and lower limb spasticity: Observational results from the ASPIRE study 52
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN POST-STROKE PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 52
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 52
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 52
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals? 51
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-Analysis 50
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 49
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 49
Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study 49
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study 49
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study 48
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature 48
Adherence to onabotulinumtoxina treatment in multiple sclerosis patients with spasticity from the aspire study 48
Differentiation among bio- and augmented- feedback in technologically assisted rehabilitation 47
Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study 47
Accurate gait analysis in post-stroke patients using a single inertial measurement unit 47
A Rare Cause of Back Pain During Pregnancy and Lactation: Management and Treatment 47
A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature 47
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 46
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 46
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity 46
Long-lasting consequences of Coronavirus disease 19 pneumonia: a systematic review 46
Administration of type a botulinum toxin after total hip replacement 46
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study 46
Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE 44
Evaluation of the safety profile of intra-articular treatment with Oxygen-Ozone therapy in knee arthrosis: controlled randomized study 44
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 43
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 43
ABOBOTULINUMTOXINA AND REHABILITATION VERSUS REHABILITATION ALONE IN POSTSTROKE SPASTICITY: AN ITALIAN COST-UTILITY ANALYSIS 43
Low back pain related to a sacral insufficiency fracture: Role of paravertebral oxygen-ozone therapy in a paradigmatic case of nociplastic pain 43
The value of adding mirror therapy for upper limb motor recovery of subacute stroke patients: a randomized controlled trial 42
Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study 42
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 41
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 41
Heart Rate Variability modifications induced by high doses of incobotulinumtoxinA and onabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study 41
Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A: A Case–Control Study 41
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 41
Long-Term Spasticity Management in Post-Stroke Patients: Issues and Possible Actions-A Systematic Review with an Italian Expert Opinion 41
IS THE OUTCOME OF DIAGNOSTIC NERVE BLOCK RELATED TO SPASTIC MUSCLE ECHO INTENSITY? A RETROSPECTIVE OBSERVATIONAL STUDY ON PATIENTS WITH SPASTIC EQUINOVARUS FOOT 41
Editorial: Long term disability in neurological disease: A rehabilitation perspective 41
Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients 40
Heart rate variability (hrv) modifications in adult hemiplegic patients after botulinum toxin type a (nt-201) injection 40
Confronto randomizzato, controllato in doppio cieco tra casting e taping nel trattamento riabilitativo dopo tossina botulinica A 40
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study 40
A single-blinded,randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot 40
Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic 39
RE: Impact of instrumental analysis of stiff knee gait on treatment appropriateness and associated costs in stroke patients 39
Sarcopenic dysphagia: a narrative review 38
Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study 38
Is the Silfverskiöld Test a valid tool for evaluating calf muscles spastic overactivity in patients with stroke? A retrospective observational study 37
Early botulinum toxin type a injection for post-stroke spasticity: A longitudinal cohort study 36
The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A 36
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation 36
Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation 36
Peripheral facial nerve palsy: how effective is rehabilitation? 36
Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis 36
Does altering inclination alter effectiveness of treadmill training for gait impairment after stroke? A randomized controlled trial 35
Spasticity Treatment During COVID-19 Pandemic: Clinical Recommendations 35
Short-wave diathermy for spastic equinus foot in chronic stroke patients: a proof-of-concept pilot study 35
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 35
Robotic gait training is not superior to conventional treadmill training in parkinson disease: a single-blind randomized controlled trial 35
People with Spinal Cord Injury in Italy 35
Post-stroke spasticity as a condition: A new perspective on patient evaluation 35
Management of stroke patients submitted to botulinum toxin type a therapy: A Delphi survey of an Italian expert panel of specialist injectors 34
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 34
Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From in vitro and in vivo Studies 34
Can scoliosis lead to spinal cord ischaemia? Early diagnosis and rehabilitation: A paradigmatic case report and literature review 34
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 34
High-Intensity Exercise Training Impact on Cardiorespiratory Fitness, Gait Ability, and Balance in Stroke Survivors: A Systematic Review and Meta-Analysis 34
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 34
Effects of robot-assisted gait training on postural instability in parkinson's disease: A systematic review 34
Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect 34
Chronic stroke: an oxymoron or a challenge for rehabilitation? 34
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 33
From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients 32
Indicatori di qualità per la continuità delle cure in Medicina Riabilitativa 32
The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis 32
Development of new biomarkers in the prevention of lymphedema related to breast cancer: a multidisciplinary challenge 32
Rectus femoris characteristics in post stroke spasticity: Clinical implications from ultrasonographic evaluation 32
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 31
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study 31
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 30
Falls, fractures and bone density in Parkinson’s disease–a cross-sectional study 30
Totale 4.491
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.629
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.439 0 0 208 71 24 165 74 75 233 302 144 143
2025/20263.283 425 279 210 250 133 167 878 164 183 200 146 248
2026/2027234 181 53 0 0 0 0 0 0 0 0 0 0
Totale 4.956